Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

autologous anti-TM4SF1 CAR-T cells

A preparation of autologous T lymphocytes that have been genetically engineered to express a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) transmembrane 4 L six family member 1 (TM4SF1) and containing a safety/kill switch composed of a truncated form of the human epidermal growth factor receptor (ErbB1t; EGFRt HER1t), with potential immunostimulating and antineoplastic activities. Upon administration, the autologous anti-TM4SF1 CAR-T cells specifically recognize and bind to TM4SF1-expressing tumor cells, resulting in tumor cell lysis. TM4SF1 plays a key role in the regulation of cell development, activation, growth and motility, and is overexpressed by a variety of tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:anti-TM4SF1-CAR-expressing autologous T cells
autologous TM4SF1-CAR T cells
autologous TM4SF1-positive CAR T cells
autologous TM4SF1-positive CAR-T cells
TM4SF1-CAR-expressing autologous T cells
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search